文献速递功能神经外科

穆西莫经对流增强递送治疗耐药性癫痫患者的研究

Convection-Enhanced Delivery of Muscimol in Patients with Drug-Resistant Epilepsy.
PubMed 文献 · Neurosurgery · 2019-01-01

这项1期临床试验在3例耐药性癫痫成人患者中,采用交叉设计经对流增强递送向癫痫灶输注人工脑脊液载体后输注穆西莫12至24小时。结果显示,穆西莫输注期间3例中1例癫痫发作频率下降,而载体输注期间所有患者发作频率均无变化;所有患者发作间期神经功能正常,切除标本病理检查未见输注相关脑损伤。结论认为穆西莫对流增强递送未损害邻近脑实质或不良影响癫痫手术结局,但未证实其有效抑制癫痫发作,建议未来研究使用替代示踪剂追踪输注分布。

要点

  • 穆西莫输注期间3例中1例癫痫发作频率下降,载体输注期间所有患者无变化。
  • 所有患者发作间期神经功能正常,病理未见输注相关脑损伤。
  • 输注液体MRI信号不足,无法追踪输注分布。

核心结论

  • 穆西莫经对流增强递送至耐药性癫痫患者癫痫灶未损害邻近脑实质或不良影响癫痫手术结局。
  • 本研究未证实脑内穆西莫输注有效抑制癫痫发作。
  • 建议未来使用对流增强递送抑制癫痫灶的研究采用替代示踪剂追踪输注至癫痫灶及周围结构的分布。

研究设计与样本

  • 1期临床试验,纳入3例耐药性癫痫成人患者。
  • 采用交叉设计,经对流增强递送向癫痫灶输注人工脑脊液载体后输注穆西莫,各持续12至24小时。
  • 通过评估输注对癫痫发作频率、脑电图尖慢波活动和功率谱脑电图频率的影响,检查癫痫灶基本病理生理。

主要发现

  • 穆西莫输注期间3例中1例癫痫发作频率下降,载体输注期间所有患者发作频率无变化。
  • 所有患者发作间期神经功能保持正常。
  • 切除标本病理检查显示无输注相关脑损伤。
  • 输注期间各时段平均β频率无显著差异。
  • 输注液体提供的MRI信号不足,无法追踪输注分布。

临床怎么用

  • 穆西莫经对流增强递送未损害邻近脑实质或不良影响癫痫手术结局,但未证实有效抑制癫痫发作。
  • 作者建议未来使用对流增强递送抑制癫痫灶的研究采用替代示踪剂追踪输注至癫痫灶及周围结构的分布。

局限性

  • 本研究未证实脑内穆西莫输注有效抑制癫痫发作。
  • 输注液体提供的MRI信号不足,无法追踪输注分布。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive therapies for drug-resistant epilepsy (DRE) have been advocated. A study of convection-enhanced delivery (CED) of muscimol, a GABAA receptor agonist, was previously completed in non-human primates. OBJECTIVE: To investigate the safety and anti-epileptic effects of intracerebral muscimol infusion into the epileptic focus of patients with DRE. METHODS: In this phase 1 clinical trial, 3 adult patients with DRE underwent CED into the seizure focus of artificial CSF vehicle followed by muscimol for 12 to 24 h each using a crossover design. Basic pathophysiology of the epileptic focus was examined by assessing the infusions' effects on seizure frequency, electroencephalogram (EEG) spike-wave activity, and power-spectral EEG frequency. RESULTS: Inter-ictal neurological function remained normal in all patients. Pathological examination of resected specimens showed no infusion-related brain injuries. Seizure frequency decreased in 1 of 3 patients during muscimol infusion but was unchanged in all patients during vehicle infusion. Mean beta frequencies did not differ significantly before, during, or after infusion periods. Infused fluid provided insufficient MRI-signal to track infusate distribution. In the 2 yr after standard epilepsy surgery, 1 patient had temporary reduction in seizure frequency and 2 patients were seizure-free. CONCLUSION: CED of muscimol into the epileptic focus of patients with DRE did not damage adjacent brain parenchyma or adversely affect seizure surgery outcome. This study did not confirm that intracerebral muscimol infusion effectively suppressed seizures. A surrogate tracer is recommended to track infusion distribution to the epileptic focus and surrounding structures in future studies using CED to suppress the seizure focus.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Heiss JD, Argersinger DP, Theodore WH, et al. Convection-Enhanced Delivery of Muscimol in Patients with Drug-Resistant Epilepsy. Neurosurgery. 2019. PMID: 30407567. doi:10.1093/neuros/nyy480

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。